{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T06:37:59Z","timestamp":1790145479828,"version":"4.0.1"},"reference-count":274,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medical Clinics of North America"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1016\/j.mcna.2013.04.005","type":"journal-article","created":{"date-parts":[[2013,6,5]],"date-time":"2013-06-05T06:51:44Z","timestamp":1370415104000},"page":"911-946","source":"Crossref","is-referenced-by-count":86,"title":["Diagnosis and Management of Infection in the Diabetic Foot"],"prefix":"10.1016","volume":"97","author":[{"given":"Edgar J.G.","family":"Peters","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin A.","family":"Lipsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mcna.2013.04.005_bib1","series-title":"Diabetes in America","first-page":"485","article-title":"Infection and diabetes mellitus","author":"Boyko","year":"1995"},{"issue":"1","key":"10.1016\/j.mcna.2013.04.005_bib2","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/dmrr.682","article-title":"Common infections in diabetes: pathogenesis, management and relationship to glycaemic control","volume":"23","author":"Peleg","year":"2007","journal-title":"Diabetes Metab Res Rev"},{"issue":"5","key":"10.1016\/j.mcna.2013.04.005_bib3","doi-asserted-by":"crossref","first-page":"513","DOI":"10.2337\/diacare.13.5.513","article-title":"Pathways to diabetic limb amputation. Basis for prevention","volume":"13","author":"Pecoraro","year":"1990","journal-title":"Diabetes Care"},{"issue":"5","key":"10.1016\/j.mcna.2013.04.005_bib4","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.2337\/diacare.26.5.1435","article-title":"Diabetic foot syndrome: evaluating the prevalence and incidence of foot pathology in Mexican Americans and non-Hispanic whites from a diabetes disease management cohort","volume":"26","author":"Lavery","year":"2003","journal-title":"Diabetes Care"},{"issue":"5\u20136","key":"10.1016\/j.mcna.2013.04.005_bib5","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/S1056-8727(99)00065-3","article-title":"Deep foot infections in patients with diabetes and foot ulcer: an entity with different characteristics, treatments, and prognosis","volume":"13","author":"Eneroth","year":"1999","journal-title":"J\u00a0Diabetes Complications"},{"issue":"7","key":"10.1016\/j.mcna.2013.04.005_bib6","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.2337\/diacare.22.7.1029","article-title":"Lower-extremity amputation in diabetes. The independent effects of peripheral vascular disease, sensory neuropathy, and foot ulcers","volume":"22","author":"Adler","year":"1999","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.mcna.2013.04.005_bib7","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jdiacomp.2007.04.004","article-title":"Epidemiology of diabetic foot problems and predictive factors for limb loss","volume":"22","author":"Nather","year":"2008","journal-title":"J\u00a0Diabetes Complications"},{"issue":"5","key":"10.1016\/j.mcna.2013.04.005_bib8","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1007\/s00125-008-0940-0","article-title":"Prediction of outcome in individuals with diabetic foot ulcers: focus on the differences between individuals with and without peripheral arterial disease. The EURODIALE Study","volume":"51","author":"Prompers","year":"2008","journal-title":"Diabetologia"},{"issue":"11","key":"10.1016\/j.mcna.2013.04.005_bib9","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1177\/107110079701801107","article-title":"Clinical characteristics and outcome in 223 diabetic patients with deep foot infections","volume":"18","author":"Eneroth","year":"1997","journal-title":"Foot Ankle Int"},{"issue":"3","key":"10.1016\/j.mcna.2013.04.005_bib10","doi-asserted-by":"crossref","first-page":"225","DOI":"10.2165\/00019053-200018030-00003","article-title":"Costs of deep foot infections in patients with diabetes mellitus","volume":"18","author":"Ragnarson Tennvall","year":"2000","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.mcna.2013.04.005_bib11","unstructured":"US Census Bureau, Washington, DC. Inflation calculator. 2013. Available at: www.bls.gov\/data\/inflation_calculator.htm\/. Accessed February 2, 2013."},{"issue":"5","key":"10.1016\/j.mcna.2013.04.005_bib12","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1111\/dme.12074","article-title":"An antibiotic formulary for a tertiary care foot clinic: admission avoidance using intramuscular antibiotics for borderline foot infections in people with diabetes","volume":"30","author":"Gooday","year":"2013","journal-title":"Diabet Med"},{"issue":"10","key":"10.1016\/j.mcna.2013.04.005_bib13","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1007\/s00125-010-1828-3","article-title":"Beneficial effects of implementing guidelines on microbiology and costs of infected diabetic foot ulcers","volume":"53","author":"Sotto","year":"2010","journal-title":"Diabetologia"},{"key":"10.1016\/j.mcna.2013.04.005_bib14","unstructured":"International Working Group on the Diabetic Foot. International Consensus on the Diabetic Foot and Supplements, DVD. 2011; Complete IWGDF data DVD guidelines 2011. Available at: http:\/\/shop.idf.org. Accessed February 2, 2013."},{"key":"10.1016\/j.mcna.2013.04.005_bib15","first-page":"90","article-title":"Infection in the diabetic foot","author":"Berendt","year":"2005"},{"issue":"6","key":"10.1016\/j.mcna.2013.04.005_bib16","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1086\/516149","article-title":"Staging and staging application in osteomyelitis","volume":"25","author":"Mader","year":"1997","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.mcna.2013.04.005_bib17","doi-asserted-by":"crossref","first-page":"510","DOI":"10.2337\/diacare.26.2.510","article-title":"Quantifying the risk of infectious diseases for people with diabetes","volume":"26","author":"Shah","year":"2003","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1016\/j.mcna.2013.04.005_bib18","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1086\/431587","article-title":"Increased risk of common infections in patients with type 1 and type 2 diabetes mellitus","volume":"41","author":"Muller","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.mcna.2013.04.005_bib19","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1056\/NEJMoa052521","article-title":"Intensive insulin therapy in the medical ICU","volume":"354","author":"van den Berghe","year":"2006","journal-title":"N\u00a0Engl J Med"},{"issue":"19","key":"10.1016\/j.mcna.2013.04.005_bib20","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1056\/NEJMoa011300","article-title":"Intensive insulin therapy in the critically ill patients","volume":"345","author":"van den Berghe","year":"2001","journal-title":"N\u00a0Engl J Med"},{"issue":"8","key":"10.1016\/j.mcna.2013.04.005_bib21","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1503\/cmaj.090206","article-title":"Intensive insulin therapy and mortality among critically ill patients: a meta-analysis including NICE-SUGAR study data","volume":"180","author":"Griesdale","year":"2009","journal-title":"CMAJ"},{"issue":"8","key":"10.1016\/j.mcna.2013.04.005_bib22","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1503\/cmaj.090500","article-title":"Intensive insulin therapy in the intensive care unit","volume":"180","author":"Van den Berghe","year":"2009","journal-title":"CMAJ"},{"issue":"5","key":"10.1016\/j.mcna.2013.04.005_bib23","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1055\/s-2004-814489","article-title":"The role of nitric oxide in the development of diabetic angiopathy","volume":"36","author":"Santilli","year":"2004","journal-title":"Horm Metab Res"},{"issue":"2","key":"10.1016\/j.mcna.2013.04.005_bib24","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1080\/10623320303362","article-title":"Effects of acute hyperglycemia on endothelium-dependent vasodilation in patients with diabetes mellitus or impaired glucose metabolism","volume":"10","author":"Kim","year":"2003","journal-title":"Endothelium"},{"issue":"3","key":"10.1016\/j.mcna.2013.04.005_bib25","first-page":"121","article-title":"Complement activation in diabetes mellitus","volume":"35","author":"Bergamaschini","year":"1991","journal-title":"J\u00a0Clin Lab Immunol"},{"issue":"2","key":"10.1016\/j.mcna.2013.04.005_bib26","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1155\/EDR.2003.125","article-title":"Hyperglycemia-induced protein kinase C activation inhibits phagocytosis of C3b- and immunoglobulin g-opsonized yeast particles in normal human neutrophils","volume":"4","author":"Saiepour","year":"2003","journal-title":"Exp Diabesity Res"},{"issue":"3","key":"10.1016\/j.mcna.2013.04.005_bib27","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s00011-005-0009-1","article-title":"Insulin inhibits phagocytosis in normal human\u00a0neutrophils via PKCalpha\/beta-dependent priming of F-actin assembly","volume":"55","author":"Saiepour","year":"2006","journal-title":"Inflamm Res"},{"issue":"7","key":"10.1016\/j.mcna.2013.04.005_bib28","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1097\/01.CCM.0000170106.61978.D8","article-title":"Acute hyperglycemia and the innate immune system:\u00a0clinical, cellular, and molecular aspects","volume":"33","author":"Turina","year":"2005","journal-title":"Crit Care Med"},{"issue":"1","key":"10.1016\/j.mcna.2013.04.005_bib29","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/(SICI)1096-9136(199701)14:1<29::AID-DIA300>3.0.CO;2-V","article-title":"Impaired leucocyte functions in diabetic patients","volume":"14","author":"Delamaire","year":"1997","journal-title":"Diabet Med"},{"issue":"4","key":"10.1016\/j.mcna.2013.04.005_bib30","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1007\/s00134-002-1628-4","article-title":"High glucose impairs superoxide production from isolated blood neutrophils","volume":"29","author":"Perner","year":"2003","journal-title":"Intensive Care Med"},{"issue":"3\u20134","key":"10.1016\/j.mcna.2013.04.005_bib31","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.1574-695X.1999.tb01397.x","article-title":"Immune dysfunction in patients with diabetes mellitus (DM)","volume":"26","author":"Geerlings","year":"1999","journal-title":"FEMS Immunol Med Microbiol"},{"issue":"5","key":"10.1016\/j.mcna.2013.04.005_bib32","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1055\/s-2007-1003298","article-title":"Insulin, at physiological concentrations, enhances the polymorphonuclear leukocyte chemotactic properties","volume":"24","author":"Cavalot","year":"1992","journal-title":"Horm Metab Res"},{"issue":"12","key":"10.1016\/j.mcna.2013.04.005_bib33","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1056\/NEJM197103252841201","article-title":"Chemotaxis of polymorphonuclear leukocytes from patients with diabetes mellitus","volume":"284","author":"Mowat","year":"1971","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.mcna.2013.04.005_bib34","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1007\/BF00919141","article-title":"Defective monocyte chemotactic responses in diabetes mellitus","volume":"3","author":"Hill","year":"1983","journal-title":"J\u00a0Clin Immunol"},{"issue":"6","key":"10.1016\/j.mcna.2013.04.005_bib35","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1189\/jlb.0104050","article-title":"In\u00a0vivo evidences that insulin regulates human polymorphonuclear neutrophil functions","volume":"76","author":"Walrand","year":"2004","journal-title":"J\u00a0Leukoc Biol"},{"issue":"3","key":"10.1016\/j.mcna.2013.04.005_bib36","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1189\/jlb.71.3.433","article-title":"RAGE-mediated neutrophil dysfunction is evoked by advanced glycation end products (AGEs)","volume":"71","author":"Collison","year":"2002","journal-title":"J\u00a0Leukoc Biol"},{"issue":"9081","key":"10.1016\/j.mcna.2013.04.005_bib37","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/S0140-6736(97)04495-4","article-title":"Randomised placebo-controlled trial of granulocyte-colony stimulating factor in diabetic foot infection","volume":"350","author":"Gough","year":"1997","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.mcna.2013.04.005_bib38","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1046\/j.1463-1326.2001.00142.x","article-title":"Effects of granulocyte-colony stimulating factor in the treatment of diabetic foot infection","volume":"3","author":"Y\u00f6nem","year":"2001","journal-title":"Diabetes Obes Metab"},{"issue":"2","key":"10.1016\/j.mcna.2013.04.005_bib39","doi-asserted-by":"crossref","first-page":"454","DOI":"10.2337\/diacare.28.2.454","article-title":"Are granulocyte colony-stimulating factors beneficial in treating diabetic foot infections?: A meta-analysis","volume":"28","author":"Cruciani","year":"2005","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1016\/j.mcna.2013.04.005_bib40","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD006810.pub2","article-title":"Granulocyte-colony stimulating factors as adjunctive therapy for diabetic foot infections","author":"Cruciani","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"issue":"1\u20132","key":"10.1016\/j.mcna.2013.04.005_bib41","first-page":"68","article-title":"Cytotoxic T-cell response to influenza A subunit vaccine in patients with type 1 diabetes mellitus","volume":"35","author":"Diepersloot","year":"1989","journal-title":"Neth J Med"},{"issue":"2\u20133","key":"10.1016\/j.mcna.2013.04.005_bib42","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/S0264-410X(97)88328-4","article-title":"Systemic and local immune responses after parenteral influenza vaccination in juvenile diabetic patients and healthy controls: results from a pilot study","volume":"16","author":"el-Madhun","year":"1998","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.mcna.2013.04.005_bib43","doi-asserted-by":"crossref","first-page":"119","DOI":"10.2337\/diabetes.30.2.119","article-title":"Pneumococcal immunization in adult diabetics","volume":"30","author":"Lederman","year":"1981","journal-title":"Diabetes"},{"issue":"7\u20138","key":"10.1016\/j.mcna.2013.04.005_bib44","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/S0264-410X(00)00268-1","article-title":"Long term persistence of anti-HBs protective levels in young patients with type 1 diabetes after recombinant hepatitis B vaccine","volume":"19","author":"Marseglia","year":"2000","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.mcna.2013.04.005_bib45","doi-asserted-by":"crossref","first-page":"708","DOI":"10.2337\/diab.23.8.708","article-title":"Phytohemagglutinin transformation and circulating lymphocyte subpopulations in insulin-dependent diabetic patients","volume":"23","author":"MacCuish","year":"1974","journal-title":"Diabetes"},{"issue":"3","key":"10.1016\/j.mcna.2013.04.005_bib46","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1006\/clim.2002.5220","article-title":"Impaired primary immune response in type-1 diabetes: results from a controlled vaccination study","volume":"103","author":"Eibl","year":"2002","journal-title":"Clin Immunol"},{"issue":"1","key":"10.1016\/j.mcna.2013.04.005_bib47","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0008-8749(03)00043-1","article-title":"Impaired primary immune response in type-1 diabetes. Functional impairment at the level of APCs and T-cells","volume":"221","author":"Spatz","year":"2003","journal-title":"Cell Immunol"},{"issue":"1","key":"10.1016\/j.mcna.2013.04.005_bib48","first-page":"5","article-title":"In\u00a0vivo determination of cell mediated immune response in diabetic patients using a multiple intradermal antigen dispenser","volume":"6","author":"Pozzilli","year":"1987","journal-title":"Diabetes Res"},{"issue":"6","key":"10.1016\/j.mcna.2013.04.005_bib49","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.2337\/dc05-2425","article-title":"Risk factors for foot infections in individuals with diabetes","volume":"29","author":"Lavery","year":"2006","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.mcna.2013.04.005_bib50","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jdiacomp.2004.06.002","article-title":"Diabetic lower extremity infection: influence of physical, psychological, and social factors","volume":"19","author":"Peters","year":"2005","journal-title":"J\u00a0Diabetes Complications"},{"issue":"17","key":"10.1016\/j.mcna.2013.04.005_bib51","first-page":"527","article-title":"Risk factors for diabetic foot in recipients of renal and pancreatic transplants","volume":"136","author":"Bartos","year":"1997","journal-title":"Cas Lek Cesk"},{"issue":"3","key":"10.1016\/j.mcna.2013.04.005_bib52","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1177\/1534734604267768","article-title":"An audit of foot infections in patients with diabetes mellitus following renal transplantation","volume":"3","author":"George","year":"2004","journal-title":"Int J Low Extrem Wounds"},{"issue":"4","key":"10.1016\/j.mcna.2013.04.005_bib53","first-page":"381","article-title":"Risk of foot complications in long-term diabetic patients with and without ESRD: a preliminary study","volume":"23","author":"Hill","year":"1996","journal-title":"ANNA J"},{"issue":"2","key":"10.1016\/j.mcna.2013.04.005_bib54","first-page":"692","article-title":"Is walking barefoot a risk factor for diabetic foot disease in developing countries?","volume":"7","author":"Jayasinghe","year":"2007","journal-title":"Rural Remote Health"},{"issue":"Suppl 1","key":"10.1016\/j.mcna.2013.04.005_bib55","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1002\/dmrr.464","article-title":"Diabetic foot ulcer classification system for research purposes: a progress report on criteria for including patients in research studies","volume":"20","author":"Schaper","year":"2004","journal-title":"Diabetes Metab Res Rev"},{"issue":"12","key":"10.1016\/j.mcna.2013.04.005_bib56","doi-asserted-by":"crossref","first-page":"e132","DOI":"10.1093\/cid\/cis346","article-title":"2012 Infectious Diseases Society of America clinical practice guideline for the diagnosis and treatment of diabetic foot infections","volume":"54","author":"Lipsky","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"12","key":"10.1016\/j.mcna.2013.04.005_bib57","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.2337\/diacare.18.12.1588","article-title":"Infected puncture wounds in diabetic and nondiabetic adults","volume":"18","author":"Lavery","year":"1995","journal-title":"Diabetes Care"},{"issue":"Suppl 2","key":"10.1016\/j.mcna.2013.04.005_bib58","doi-asserted-by":"crossref","first-page":"S83","DOI":"10.1086\/383267","article-title":"Diagnosing foot infection in diabetes","volume":"39","author":"Williams","year":"2004","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.mcna.2013.04.005_bib59","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1177\/1534734609337930","article-title":"Double trouble: infection and ischemia in the diabetic foot","volume":"8","author":"Edmonds","year":"2009","journal-title":"Int J Low Extrem Wounds"},{"issue":"Suppl 1","key":"10.1016\/j.mcna.2013.04.005_bib60","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1002\/dmrr.2234","article-title":"Diabetes and foot infection: more than double trouble","volume":"28","author":"Richard","year":"2012","journal-title":"Diabetes Metab Res Rev"},{"issue":"20","key":"10.1016\/j.mcna.2013.04.005_bib61","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1001\/archinte.1996.00440190131013","article-title":"The acutely infected diabetic foot is not adequately evaluated in an inpatient setting","volume":"156","author":"Edelson","year":"1996","journal-title":"Arch Intern Med"},{"issue":"5","key":"10.1016\/j.mcna.2013.04.005_bib62","doi-asserted-by":"crossref","first-page":"224","DOI":"10.7547\/87507315-86-5-224","article-title":"Value of white blood cell count with differential in the acute diabetic foot infection","volume":"86","author":"Armstrong","year":"1996","journal-title":"J\u00a0Am Podiatr Med Assoc"},{"issue":"5","key":"10.1016\/j.mcna.2013.04.005_bib63","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0002-9343(96)00283-5","article-title":"Puncture wounds: normal laboratory\u00a0values in the face of severe infection in diabetics and non-diabetics","volume":"101","author":"Lavery","year":"1996","journal-title":"Am J Med"},{"key":"10.1016\/j.mcna.2013.04.005_bib64","first-page":"227","article-title":"Surgical management of the diabetic foot","volume":"16","author":"Meggitt","year":"1976","journal-title":"Br J Hosp Med"},{"key":"10.1016\/j.mcna.2013.04.005_bib65","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1177\/107110078100200202","article-title":"The dysvascular foot: a system for diagnosis and treatment","volume":"2","author":"Wagner","year":"1981","journal-title":"Foot Ankle"},{"issue":"4","key":"10.1016\/j.mcna.2013.04.005_bib66","first-page":"123","article-title":"Classification of diabetic foot ulcers: the S(AD) SAD system","volume":"2","author":"Macfarlane","year":"1999","journal-title":"Diabet Foot"},{"issue":"9","key":"10.1016\/j.mcna.2013.04.005_bib67","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1111\/j.1464-5491.2004.01275.x","article-title":"Validation of a system of foot ulcer classification in diabetes mellitus","volume":"21","author":"Treece","year":"2004","journal-title":"Diabet Med"},{"issue":"8","key":"10.1016\/j.mcna.2013.04.005_bib68","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.2337\/dc06-0306","article-title":"Assessing the outcome of the management\u00a0of diabetic foot ulcers using ulcer-related and person-related measures","volume":"29","author":"Jeffcoate","year":"2006","journal-title":"Diabetes Care"},{"issue":"5","key":"10.1016\/j.mcna.2013.04.005_bib69","doi-asserted-by":"crossref","first-page":"855","DOI":"10.2337\/diacare.21.5.855","article-title":"Validation of a diabetic wound classification system. The contribution of depth, infection, and ischemia to risk of amputation","volume":"21","author":"Armstrong","year":"1998","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.mcna.2013.04.005_bib70","doi-asserted-by":"crossref","first-page":"84","DOI":"10.2337\/diacare.24.1.84","article-title":"A\u00a0comparison of two diabetic foot ulcer classification systems: the Wagner and the University of Texas wound classification systems","volume":"24","author":"Oyibo","year":"2001","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1016\/j.mcna.2013.04.005_bib71","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1097\/00000658-198609000-00011","article-title":"Classification and treatment of chronic nonhealing wounds. Successful treatment with autologous platelet-derived wound healing factors (PDWHF)","volume":"204","author":"Knighton","year":"1986","journal-title":"Ann Surg"},{"issue":"5","key":"10.1016\/j.mcna.2013.04.005_bib72","doi-asserted-by":"crossref","first-page":"988","DOI":"10.2337\/dc05-2431","article-title":"A\u00a0new wound-based severity score for diabetic foot ulcers: a prospective analysis of 1,000 patients","volume":"29","author":"Beckert","year":"2006","journal-title":"Diabetes Care"},{"issue":"4","key":"10.1016\/j.mcna.2013.04.005_bib73","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1097\/SLA.0b013e31819eda06","article-title":"M.A.I.D.: a prognostic score estimating probability of healing in chronic lower extremity wounds","volume":"249","author":"Beckert","year":"2009","journal-title":"Ann Surg"},{"issue":"5","key":"10.1016\/j.mcna.2013.04.005_bib74","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1111\/j.1524-475X.2009.00521.x","article-title":"The value of a wound score for diabetic foot infections in predicting treatment outcome: a prospective analysis from the SIDESTEP trial","volume":"17","author":"Lipsky","year":"2009","journal-title":"Wound Repair Regen"},{"issue":"1","key":"10.1016\/j.mcna.2013.04.005_bib75","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1086\/380449","article-title":"Treating foot infections in diabetic patients: a randomized, multicenter, open-label trial of linezolid versus ampicillin-sulbactam\/amoxicillin-clavulanate","volume":"38","author":"Lipsky","year":"2004","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.mcna.2013.04.005_bib76","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0732-8893(99)00056-5","article-title":"In\u00a0vitro susceptibility to pexiganan of bacteria isolated from infected diabetic foot ulcers","volume":"35","author":"Ge","year":"1999","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.mcna.2013.04.005_bib77","first-page":"A354","article-title":"Does a diabetic foot infection (DFI) wound score correlate with the clinical response to antibiotic treatment? Data from the SIDESTEP study","volume":"48","author":"Lipsky","year":"2005","journal-title":"Diabetologia"},{"issue":"9498","key":"10.1016\/j.mcna.2013.04.005_bib78","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1016\/S0140-6736(05)67694-5","article-title":"Ertapenem versus piperacillin\/tazobactam for diabetic foot infections (SIDESTEP): prospective, randomised, controlled, double-blinded, multicentre trial","volume":"366","author":"Lipsky","year":"2005","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.mcna.2013.04.005_bib79","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4103\/0973-3930.50707","article-title":"Implementation of diabetic foot ulcer\u00a0classification system for research purposes to predict lower extremity amputation","volume":"29","author":"Widatalla","year":"2009","journal-title":"Int J Diabetes Dev Ctries"},{"issue":"4","key":"10.1016\/j.mcna.2013.04.005_bib80","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1086\/511036","article-title":"Validation of the Infectious Diseases Society of America's diabetic foot infection classification system","volume":"44","author":"Lavery","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.mcna.2013.04.005_bib81","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s00125-006-0491-1","article-title":"High prevalence of ischaemia, infection and serious comorbidity in patients with diabetic foot disease in Europe. Baseline results from the Eurodiale study","volume":"50","author":"Prompers","year":"2007","journal-title":"Diabetologia"},{"issue":"2","key":"10.1016\/j.mcna.2013.04.005_bib82","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s00125-007-0840-8","article-title":"Serum procalcitonin and C-reactive\u00a0protein concentrations to distinguish mildly infected from non-infected diabetic foot ulcers: a pilot study","volume":"51","author":"Jeandrot","year":"2008","journal-title":"Diabetologia"},{"issue":"7","key":"10.1016\/j.mcna.2013.04.005_bib83","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1086\/424846","article-title":"Diagnosis and treatment of diabetic foot infections","volume":"39","author":"Lipsky","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.mcna.2013.04.005_bib84","first-page":"18","article-title":"Should antibiotics be used in the treatment of the diabetic foot?","volume":"6","author":"Berendt","year":"2003","journal-title":"Diabet Foot"},{"issue":"2","key":"10.1016\/j.mcna.2013.04.005_bib85","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1002\/(SICI)1096-9136(199602)13:2<156::AID-DIA59>3.0.CO;2-U","article-title":"Antibiotic treatment for uncomplicated neuropathic forefoot ulcers in diabetes: a controlled trial","volume":"13","author":"Chantelau","year":"1996","journal-title":"Diabet Med"},{"key":"10.1016\/j.mcna.2013.04.005_bib86","series-title":"Should oral antibiotics be given to \u201cclean\u201d foot ulcers with no cellulitis?","author":"Foster","year":"1999"},{"issue":"Suppl 1","key":"10.1016\/j.mcna.2013.04.005_bib87","doi-asserted-by":"crossref","first-page":"S171","DOI":"10.1093\/clinids\/6.Supplement_1.S171","article-title":"The infected foot of the diabetic patient: quantitative microbiology and analysis of clinical features","volume":"6","author":"Sapico","year":"1984","journal-title":"Rev Infect Dis"},{"issue":"4","key":"10.1016\/j.mcna.2013.04.005_bib88","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1001\/archinte.1990.00390160058013","article-title":"Outpatient management of uncomplicated lower-extremity infections in diabetic patients","volume":"150","author":"Lipsky","year":"1990","journal-title":"Arch Intern Med"},{"issue":"1","key":"10.1016\/j.mcna.2013.04.005_bib89","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1086\/498112","article-title":"Culture of percutaneous bone biopsy specimens for diagnosis of diabetic foot osteomyelitis: concordance with ulcer swab cultures","volume":"42","author":"Senneville","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.mcna.2013.04.005_bib90","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1086\/498121","article-title":"Microbiological evaluation of diabetic foot osteomyelitis","volume":"42","author":"Embil","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"11","key":"10.1016\/j.mcna.2013.04.005_bib91","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1046\/j.1464-5491.2000.00374-2.x","article-title":"Bacteria in superficial diabetic foot ulcers","volume":"17","author":"Urbancic-Rovan","year":"2000","journal-title":"Diabet Med"},{"issue":"3","key":"10.1016\/j.mcna.2013.04.005_bib92","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0891-5520(20)30354-8","article-title":"The diabetic foot. Soft tissue and bone infection","volume":"4","author":"Lipsky","year":"1990","journal-title":"Infect Dis Clin North Am"},{"issue":"6","key":"10.1016\/j.mcna.2013.04.005_bib93","doi-asserted-by":"crossref","first-page":"638","DOI":"10.2337\/diacare.19.6.638","article-title":"Diabetic foot infections. Bacteriology and activity of 10 oral antimicrobial agents against bacteria isolated from consecutive cases","volume":"19","author":"Goldstein","year":"1996","journal-title":"Diabetes Care"},{"issue":"12","key":"10.1016\/j.mcna.2013.04.005_bib94","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1046\/j.1464-5491.2002.00696_1.x","article-title":"Microbiological profile of infected diabetic foot ulcers","volume":"19","author":"Ge","year":"2002","journal-title":"Diabet Med"},{"issue":"8","key":"10.1016\/j.mcna.2013.04.005_bib95","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.2337\/dc06-0116","article-title":"A\u00a0clinico-microbiological study of diabetic foot ulcers in an Indian tertiary care hospital","volume":"29","author":"Gadepalli","year":"2006","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1016\/j.mcna.2013.04.005_bib96","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.jdiacomp.2004.06.001","article-title":"Bacteriological study of diabetic foot infections","volume":"19","author":"Abdulrazak","year":"2005","journal-title":"J\u00a0Diabetes Complications"},{"issue":"3","key":"10.1016\/j.mcna.2013.04.005_bib97","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1464-5491.1985.tb00640.x","article-title":"A\u00a0microbiological study of diabetic foot lesions","volume":"2","author":"Jones","year":"1985","journal-title":"Diabet Med"},{"issue":"8","key":"10.1016\/j.mcna.2013.04.005_bib98","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1111\/j.1464-5491.1992.tb01885.x","article-title":"Foot infections in diabetes are rarely due to a single microorganism","volume":"9","author":"Hunt","year":"1992","journal-title":"Diabet Med"},{"issue":"2","key":"10.1016\/j.mcna.2013.04.005_bib99","first-page":"33","article-title":"Gram-negative bacterial surveillance in diabetic patients","volume":"10","author":"Louie","year":"1993","journal-title":"Infect Med"},{"issue":"5","key":"10.1016\/j.mcna.2013.04.005_bib100","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0953-6205(03)00107-9","article-title":"Infections in diabetic foot ulcers","volume":"14","author":"Candel Gonzalez","year":"2003","journal-title":"Eur J Intern Med"},{"issue":"10","key":"10.1016\/j.mcna.2013.04.005_bib101","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1001\/archinte.1986.00360220079017","article-title":"Diabetic foot infections. Bacteriologic analysis","volume":"146","author":"Wheat","year":"1986","journal-title":"Arch Intern Med"},{"issue":"4","key":"10.1016\/j.mcna.2013.04.005_bib102","first-page":"437","article-title":"Diabetic foot infections: a study of microorganisms\u00a0associated with the different Wagner grades","volume":"41","author":"Pathare","year":"1998","journal-title":"Indian J Pathol Microbiol"},{"issue":"Suppl 2","key":"10.1016\/j.mcna.2013.04.005_bib103","doi-asserted-by":"crossref","first-page":"S283","DOI":"10.1093\/clinids\/20.Supplement_2.S283","article-title":"Foot infections in diabetic patients: the role of anaerobes","volume":"20","author":"Gerding","year":"1995","journal-title":"Clin Infect Dis"},{"issue":"7","key":"10.1016\/j.mcna.2013.04.005_bib104","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1111\/j.1464-5491.2004.01237.x","article-title":"Diabetic foot ulcer and multidrug-resistant organisms: risk factors and impact","volume":"21","author":"Hartemann-Heurtier","year":"2004","journal-title":"Diabet Med"},{"issue":"9","key":"10.1016\/j.mcna.2013.04.005_bib105","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1046\/j.1464-5491.1999.00132.x","article-title":"Methicillin-resistant Staphylococcus aureus: an increasing problem in a diabetic foot clinic","volume":"16","author":"Tentolouris","year":"1999","journal-title":"Diabet Med"},{"issue":"2","key":"10.1016\/j.mcna.2013.04.005_bib106","first-page":"186","article-title":"Prevalence of methicillin-resistant Staphylococcus aureus in infected and uninfected diabetic foot ulcers","volume":"12","author":"Tentolouris","year":"2006","journal-title":"Clin Microbiol\u00a0Infect"},{"issue":"1","key":"10.1016\/j.mcna.2013.04.005_bib107","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.diabres.2011.10.001","article-title":"Clinical and bacteriological survey\u00a0of diabetic foot infections in Lisbon","volume":"95","author":"Mendes","year":"2012","journal-title":"Diabetes Res Clin Pract"},{"issue":"2","key":"10.1016\/j.mcna.2013.04.005_bib108","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1046\/j.1464-5491.2003.00860.x","article-title":"Methicillin-resistant Staphylococcus aureus in the diabetic foot clinic: a worsening problem","volume":"20","author":"Dang","year":"2003","journal-title":"Diabet Med"},{"issue":"48","key":"10.1016\/j.mcna.2013.04.005_bib109","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1055\/s-2001-18655","article-title":"Erfahrungen im Umgang mit hochresistenten Keimen bei Patienten mit diabetischem Fu\u00df-Syndrom unter besonderer Ber\u00fccksichtigung von MRSA-Infektionen","volume":"126","author":"Wagner","year":"2001","journal-title":"Dtsch Med Wochenschr"},{"issue":"7","key":"10.1016\/j.mcna.2013.04.005_bib110","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1056\/NEJMoa055356","article-title":"Methicillin-resistant S. aureus infections\u00a0among patients in the emergency department","volume":"355","author":"Moran","year":"2006","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.mcna.2013.04.005_bib111","first-page":"439","article-title":"Risk factors for infection of the diabetic foot with multi-antibiotic resistant microorganisms","volume":"54","author":"Kandemir","year":"2007","journal-title":"J\u00a0Infect"},{"issue":"5","key":"10.1016\/j.mcna.2013.04.005_bib112","doi-asserted-by":"crossref","first-page":"25S","DOI":"10.1016\/S0002-9610(03)00300-3","article-title":"The use of antibiotics in the diabetic foot","volume":"187","author":"Edmonds","year":"2004","journal-title":"Am J Surg"},{"issue":"4","key":"10.1016\/j.mcna.2013.04.005_bib113","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/j.1464-5491.2006.01830.x","article-title":"Systematic review of methods to diagnose infection in foot ulcers in diabetes","volume":"23","author":"O'Meara","year":"2006","journal-title":"Diabet Med"},{"issue":"4","key":"10.1016\/j.mcna.2013.04.005_bib114","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1159\/000239012","article-title":"Bacterial flora in mal perforant and antimicrobial treatment with ceftriaxone","volume":"38","author":"Hirschl","year":"1992","journal-title":"Chemotherapy"},{"issue":"3","key":"10.1016\/j.mcna.2013.04.005_bib115","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.diabres.2008.01.009","article-title":"Factors associated with treatment failure in patients with diabetic foot infections: an analysis of data from randomized controlled trials","volume":"80","author":"Vardakas","year":"2008","journal-title":"Diabetes Res Clin Pract"},{"issue":"4","key":"10.1016\/j.mcna.2013.04.005_bib116","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/j.1464-5491.2006.01785.x","article-title":"Systematic review of antimicrobial treatments for diabetic foot ulcers","volume":"23","author":"Nelson","year":"2006","journal-title":"Diabet Med"},{"issue":"9","key":"10.1016\/j.mcna.2013.04.005_bib117","doi-asserted-by":"crossref","first-page":"e601","DOI":"10.1016\/j.ijid.2011.05.003","article-title":"Diabetic foot infection: a critical review of recent randomized clinical trials on antibiotic therapy","volume":"15","author":"Crouzet","year":"2011","journal-title":"Int J Infect Dis"},{"issue":"Suppl 1","key":"10.1016\/j.mcna.2013.04.005_bib118","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1002\/dmrr.2247","article-title":"A\u00a0systematic review of the effectiveness of interventions in the management of infection in the diabetic foot","volume":"28","author":"Peters","year":"2012","journal-title":"Diabetes Metab Res Rev"},{"issue":"3\u20134","key":"10.1016\/j.mcna.2013.04.005_bib119","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1574-695X.1999.tb01398.x","article-title":"Evidence-based antibiotic therapy of diabetic foot infections","volume":"26","author":"Lipsky","year":"1999","journal-title":"FEMS Immunol Med Microbiol"},{"issue":"4","key":"10.1016\/j.mcna.2013.04.005_bib120","first-page":"671","article-title":"Comparison of serum and tissue antibiotic levels in diabetes-related foot infections","volume":"110","author":"Seabrook","year":"1991","journal-title":"Surgery"},{"key":"10.1016\/j.mcna.2013.04.005_bib121","unstructured":"Raymakers JT, Heyden vd JJ, Daemen MJ, et\u00a0al. Penetration of ceftazidime in ischemic tissues. Proceedings of the Second International Symposium on the Diabetic Foot. Noordwijkerhout (The Netherlands): 1995. [abstract: P-50]."},{"issue":"3","key":"10.1016\/j.mcna.2013.04.005_bib122","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1093\/jac\/34.3.449","article-title":"Tissue concentrations of an orally administered antibiotic in diabetic patients with foot infections","volume":"34","author":"Storm","year":"1994","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"4","key":"10.1016\/j.mcna.2013.04.005_bib123","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1093\/jac\/31.4.581","article-title":"Tissue penetration of clindamycin in diabetic foot infections","volume":"31","author":"Duckworth","year":"1993","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"1","key":"10.1016\/j.mcna.2013.04.005_bib124","first-page":"17","article-title":"Tissue concentrations of ofloxacin in necrotic foot lesions of diabetic and non-diabetic patients with peripheral arterial occlusive disease","volume":"20","author":"Mueller-Buehl","year":"1991","journal-title":"Vasa"},{"issue":"1","key":"10.1016\/j.mcna.2013.04.005_bib125","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1177\/107110079801900107","article-title":"Tissue concentrations after a single-dose, orally administered ofloxacin in patients with diabetic foot infections","volume":"19","author":"Kuck","year":"1998","journal-title":"Foot Ankle Int"},{"issue":"9","key":"10.1016\/j.mcna.2013.04.005_bib126","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1128\/AAC.39.9.2161","article-title":"Absorption of ciprofloxacin in patients with diabetic gastroparesis","volume":"39","author":"Marangos","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"10.1016\/j.mcna.2013.04.005_bib127","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.ijantimicag.2005.09.003","article-title":"Linezolid reduces length of stay and duration of intravenous treatment compared with vancomycin for complicated skin and soft tissue infections due to suspected or proven methicillin-resistant Staphylococcus aureus (MRSA)","volume":"26","author":"Itani","year":"2005","journal-title":"Int J Antimicrob Agents"},{"issue":"6","key":"10.1016\/j.mcna.2013.04.005_bib128","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1128\/AAC.49.6.2260-2266.2005","article-title":"Linezolid versus vancomycin in treatment of complicated skin and soft tissue infections","volume":"49","author":"Weigelt","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"10.1016\/j.mcna.2013.04.005_bib129","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1093\/jac\/dkm271","article-title":"Linezolid tissue penetration and serum activity against strains of methicillin-resistant Staphylococcus aureus with reduced vancomycin susceptibility in diabetic patients with foot infections","volume":"60","author":"Stein","year":"2007","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"2","key":"10.1016\/j.mcna.2013.04.005_bib130","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1093\/jac\/dkh531","article-title":"Daptomycin for treating infected diabetic foot ulcers:\u00a0evidence from a randomized, controlled trial comparing daptomycin with vancomycin or semi-synthetic penicillins for complicated skin and skin-structure infections","volume":"55","author":"Lipsky","year":"2005","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"10","key":"10.1016\/j.mcna.2013.04.005_bib131","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1086\/497271","article-title":"Randomized, double-blind comparison of once-weekly dalbavancin versus twice-daily linezolid therapy for the treatment of complicated skin and skin structure infections","volume":"41","author":"Jauregui","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"10","key":"10.1016\/j.mcna.2013.04.005_bib132","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1086\/379015","article-title":"Once-weekly dalbavancin versus standard-of-care antimicrobial regimens for treatment of skin and soft-tissue infections","volume":"37","author":"Seltzer","year":"2003","journal-title":"Clin Infect Dis"},{"issue":"11","key":"10.1016\/j.mcna.2013.04.005_bib133","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1086\/429914","article-title":"Telavancin versus standard therapy\u00a0for treatment of complicated skin and soft-tissue infections due to gram-positive bacteria","volume":"40","author":"Stryjewski","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"8","key":"10.1016\/j.mcna.2013.04.005_bib134","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.clinthera.2006.08.011","article-title":"Tigecycline: a glycylcycline antimicrobial agent","volume":"28","author":"Doan","year":"2006","journal-title":"Clin Ther"},{"issue":"5","key":"10.1016\/j.mcna.2013.04.005_bib135","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1086\/526527","article-title":"A\u00a0randomized, double-blind trial comparing ceftobiprole medocaril with vancomycin plus ceftazidime for the treatment of patients with complicated skin and skin-structure infections","volume":"46","author":"Noel","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.mcna.2013.04.005_bib136","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1128\/AAC.00551-07","article-title":"Results of a double-blind, randomized trial of ceftobiprole treatment of complicated skin and skin structure infections caused by gram-positive bacteria","volume":"52","author":"Noel","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"10.1016\/j.mcna.2013.04.005_bib137","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1093\/jac\/dkm130","article-title":"Treating diabetic foot infections with\u00a0sequential intravenous to oral moxifloxacin compared with piperacillin-tazobactam\/amoxicillin-clavulanate","volume":"60","author":"Lipsky","year":"2007","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"1","key":"10.1016\/j.mcna.2013.04.005_bib138","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s15010-012-0367-x","article-title":"Efficacy and safety of IV\/PO moxifloxacin and IV piperacillin\/tazobactam followed by PO amoxicillin\/clavulanic acid in the treatment of diabetic foot infections: results of the RELIEF study","volume":"41","author":"Schaper","year":"2013","journal-title":"Infection"},{"issue":"1","key":"10.1016\/j.mcna.2013.04.005_bib139","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1177\/1534734611400259","article-title":"Seminar review: a review of the basis of surgical treatment of diabetic foot infections","volume":"10","author":"Arag\u00f3n-S\u00e1nchez","year":"2011","journal-title":"Int J Low Extrem Wounds"},{"issue":"5","key":"10.1016\/j.mcna.2013.04.005_bib140","doi-asserted-by":"crossref","first-page":"401","DOI":"10.7547\/1000401","article-title":"A\u00a0stepwise approach for surgical management of diabetic foot infections","volume":"100","author":"Fisher","year":"2010","journal-title":"J\u00a0Am Podiatr Med Assoc"},{"issue":"Suppl 1","key":"10.1016\/j.mcna.2013.04.005_bib141","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1002\/dmrr.2251","article-title":"Specific guidelines for the treatment of diabetic foot infections 2011","volume":"28","author":"Lipsky","year":"2012","journal-title":"Diabetes Metab Res Rev"},{"issue":"Suppl 1","key":"10.1016\/j.mcna.2013.04.005_bib142","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/dmrr.2248","article-title":"Expert opinion on the management of infections in the diabetic foot","volume":"28","author":"Lipsky","year":"2012","journal-title":"Diabetes Metab Res Rev"},{"issue":"2","key":"10.1016\/j.mcna.2013.04.005_bib143","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1517\/14656566.6.2.263","article-title":"Antimicrobial interventions for the management of diabetic foot infections","volume":"6","author":"Senneville","year":"2005","journal-title":"Expert Opin Pharmacother"},{"issue":"10","key":"10.1016\/j.mcna.2013.04.005_bib144","doi-asserted-by":"crossref","first-page":"533","DOI":"10.7547\/87507315-85-10-533","article-title":"1995 William J. Stickel Bronze Award. Prevalence of mixed infections in the diabetic pedal wound. A retrospective review of 112 infections","volume":"85","author":"Armstrong","year":"1995","journal-title":"J\u00a0Am Podiatr Med Assoc"},{"issue":"4","key":"10.1016\/j.mcna.2013.04.005_bib145","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1093\/clind\/24.4.643","article-title":"Antibiotic therapy for diabetic foot infections: comparison of two parenteral-to-oral regimens","volume":"24","author":"Lipsky","year":"1997","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.mcna.2013.04.005_bib146","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1093\/clinids\/18.5.683","article-title":"Use of ampicillin\/sulbactam versus imipenem\/cilastatin in the treatment of limb-threatening foot infections in diabetic patients","volume":"18","author":"Grayson","year":"1994","journal-title":"Clin Infect Dis"},{"issue":"8","key":"10.1016\/j.mcna.2013.04.005_bib147","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1097\/00007611-199108000-00009","article-title":"The diabetic foot: consequences of delayed treatment and referral","volume":"84","author":"Mills","year":"1991","journal-title":"South Med J"},{"issue":"2","key":"10.1016\/j.mcna.2013.04.005_bib148","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/jcpt.12034","article-title":"How long to treat with antibiotics following amputation in patients with diabetic foot infections? Are the 2012 IDSA DFI guidelines reasonable?","volume":"38","author":"Johnson","year":"2013","journal-title":"J\u00a0Clin Pharm Ther"},{"issue":"6","key":"10.1016\/j.mcna.2013.04.005_bib149","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/0002-9343(89)90476-2","article-title":"Therapy of lower extremity infections with ciprofloxacin in patients with diabetes mellitus, peripheral vascular disease, or both","volume":"86","author":"Peterson","year":"1989","journal-title":"Am J Med"},{"issue":"10","key":"10.1016\/j.mcna.2013.04.005_bib150","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1177\/107110070602701003","article-title":"Oral antimicrobial therapy for diabetic foot osteomyelitis","volume":"27","author":"Embil","year":"2006","journal-title":"Foot Ankle Int"},{"issue":"Suppl 1","key":"10.1016\/j.mcna.2013.04.005_bib151","doi-asserted-by":"crossref","first-page":"S119","DOI":"10.1002\/dmrr.825","article-title":"A\u00a0systematic review of the effectiveness of interventions to enhance the healing of chronic ulcers of the foot in diabetes","volume":"24","author":"Hinchliffe","year":"2008","journal-title":"Diabetes Metab Res Rev"},{"issue":"Suppl 1","key":"10.1016\/j.mcna.2013.04.005_bib152","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/dmrr.2246","article-title":"A\u00a0systematic review of interventions to enhance the healing of chronic ulcers of the foot in diabetes","volume":"28","author":"Game","year":"2012","journal-title":"Diabetes Metab Res Rev"},{"issue":"3","key":"10.1016\/j.mcna.2013.04.005_bib153","doi-asserted-by":"crossref","first-page":"231","DOI":"10.2340\/0001555576231235","article-title":"Cavity foot ulcers in diabetic patients: a comparative study of cadexomer iodine ointment and standard treatment. An economic analysis alongside a clinical trial","volume":"76","author":"Apelqvist","year":"1996","journal-title":"Acta Derm Venereol"},{"issue":"6","key":"10.1016\/j.mcna.2013.04.005_bib154","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1111\/j.1365-2133.1990.tb04198.x","article-title":"Topical treatment of necrotic foot ulcers in diabetic patients: a comparative trial of DuoDerm and MeZinc","volume":"123","author":"Apelqvist","year":"1990","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1016\/j.mcna.2013.04.005_bib155","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1097\/00006534-200109010-00011","article-title":"An in\u00a0vivo comparison of topical agents on wound repair","volume":"108","author":"Bennett","year":"2001","journal-title":"Plast Reconstr Surg"},{"issue":"1","key":"10.1016\/j.mcna.2013.04.005_bib156","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD005082.pub2","article-title":"Silver based wound dressings and topical agents for treating diabetic foot ulcers","author":"Bergin","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"10.1016\/j.mcna.2013.04.005_bib157","first-page":"254","article-title":"Maggot therapy in \u201clower-extremity hospice\u201d wound care: fewer amputations and more antibiotic-free days","volume":"95","author":"Armstrong","year":"2005","journal-title":"J\u00a0Am Podiatr\u00a0Med Assoc"},{"key":"10.1016\/j.mcna.2013.04.005_bib158","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1099\/jmm.0.47515-0","article-title":"Selective antimicrobial activity of maggots against pathogenic bacteria","volume":"57","author":"Jaklic","year":"2008","journal-title":"J\u00a0Med Microbiol"},{"issue":"1","key":"10.1016\/j.mcna.2013.04.005_bib159","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1093\/jac\/dkm407","article-title":"Maggot excretions\/secretions are differentially effective against biofilms of Staphylococcus aureus and Pseudomonas aeruginosa","volume":"61","author":"van der Plas","year":"2008","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"Suppl 1","key":"10.1016\/j.mcna.2013.04.005_bib160","doi-asserted-by":"crossref","first-page":"S145","DOI":"10.1002\/dmrr.836","article-title":"Diabetic foot osteomyelitis: a progress report on diagnosis and a systematic review of treatment","volume":"24","author":"Berendt","year":"2008","journal-title":"Diabetes Metab Res Rev"},{"issue":"3","key":"10.1016\/j.mcna.2013.04.005_bib161","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S0039-6109(02)00199-8","article-title":"Lower extremity bypass in patients with diabetic foot ulcers","volume":"83","author":"Gibbons","year":"2003","journal-title":"Surg Clin North Am"},{"key":"10.1016\/j.mcna.2013.04.005_bib162","doi-asserted-by":"crossref","DOI":"10.1111\/j.1742-481X.2011.00936.x","article-title":"Diabetic foot ulcers treated with hyperbaric oxygen therapy:\u00a0a review of the literature","author":"Bishop","year":"2012","journal-title":"Int Wound J"},{"issue":"2","key":"10.1016\/j.mcna.2013.04.005_bib163","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1086\/505207","article-title":"Point: hyperbaric oxygen is beneficial for diabetic foot wounds","volume":"43","author":"Barnes","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.mcna.2013.04.005_bib164","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1086\/505223","article-title":"Counterpoint: hyperbaric oxygen for diabetic foot wounds is not effective","volume":"43","author":"Berendt","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.mcna.2013.04.005_bib165","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD004123.pub3","article-title":"Hyperbaric oxygen therapy for chronic wounds","author":"Kranke","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"10.1016\/j.mcna.2013.04.005_bib166","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1053\/ejvs.2002.1911","article-title":"The role of hyperbaric oxygen therapy in ischaemic diabetic lower extremity ulcers: a double-blind randomised-controlled trial","volume":"25","author":"Abidia","year":"2003","journal-title":"Eur J Vasc Endovasc Surg"},{"issue":"3","key":"10.1016\/j.mcna.2013.04.005_bib167","first-page":"112","article-title":"Hyperbaric oxygen therapy in diabetic foot","volume":"38","author":"Doctor","year":"1992","journal-title":"J\u00a0Postgrad Med"},{"issue":"12","key":"10.1016\/j.mcna.2013.04.005_bib168","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.2337\/diacare.19.12.1338","article-title":"Adjunctive systemic hyperbaric oxygen therapy in treatment of severe prevalently ischemic diabetic foot ulcer. A randomized study","volume":"19","author":"Faglia","year":"1996","journal-title":"Diabetes Care"},{"issue":"5","key":"10.1016\/j.mcna.2013.04.005_bib169","doi-asserted-by":"crossref","first-page":"998","DOI":"10.2337\/dc09-1754","article-title":"Hyperbaric oxygen therapy facilitates healing of chronic foot ulcers in patients with diabetes","volume":"33","author":"L\u00f6ndahl","year":"2010","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1016\/j.mcna.2013.04.005_bib170","doi-asserted-by":"crossref","first-page":"382","DOI":"10.2337\/diacare.22.3.382","article-title":"Incidence, outcomes, and cost of foot ulcers in patients with diabetes","volume":"22","author":"Ramsey","year":"1999","journal-title":"Diabetes Care"},{"issue":"9","key":"10.1016\/j.mcna.2013.04.005_bib171","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1001\/jama.1991.03470090080036","article-title":"Unsuspected osteomyelitis in diabetic foot ulcers. Diagnosis and monitoring by leukocyte scanning with indium in 111\u00a0oxyquinoline","volume":"266","author":"Newman","year":"1991","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.mcna.2013.04.005_bib172","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1086\/516148","article-title":"Osteomyelitis of the foot in diabetic patients","volume":"25","author":"Lipsky","year":"1997","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.mcna.2013.04.005_bib173","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S1067-2516(09)80103-8","article-title":"Microbiology of osteomyelitis in diabetic foot infections","volume":"34","author":"Lavery","year":"1995","journal-title":"J\u00a0Foot Ankle Surg"},{"issue":"3","key":"10.1016\/j.mcna.2013.04.005_bib174","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s00132-003-0604-1","article-title":"Classification and microbiology of osteomyelitis","volume":"33","author":"Zimmerli","year":"2004","journal-title":"Orthopade"},{"issue":"Suppl 4","key":"10.1016\/j.mcna.2013.04.005_bib175","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1464-5491.2004.1424-8.x","article-title":"MRSA and osteomyelitis of the foot in diabetes","volume":"21","author":"Game","year":"2004","journal-title":"Diabet Med"},{"issue":"2","key":"10.1016\/j.mcna.2013.04.005_bib176","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1078\/1438-4221-00196","article-title":"Mechanisms of antibiotic resistance in bacterial biofilms","volume":"292","author":"Stewart","year":"2002","journal-title":"Int J Med Microbiol"},{"issue":"3","key":"10.1016\/j.mcna.2013.04.005_bib177","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0030-5898(20)31101-9","article-title":"Bacterial adherence and the glycocalyx and their role in musculoskeletal infection","volume":"15","author":"Gristina","year":"1984","journal-title":"Orthop Clin North Am"},{"issue":"6","key":"10.1016\/j.mcna.2013.04.005_bib178","doi-asserted-by":"crossref","first-page":"510","DOI":"10.7861\/clinmedicine.4-6-510","article-title":"Bone and joint infection","volume":"4","author":"Berendt","year":"2004","journal-title":"Clin Med"},{"issue":"898","key":"10.1016\/j.mcna.2013.04.005_bib179","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1136\/pmj.76.898.479","article-title":"Pathophysiology of chronic bacterial osteomyelitis. Why do antibiotics fail so often?","volume":"76","author":"Ciampolini","year":"2000","journal-title":"Postgrad Med J"},{"issue":"2","key":"10.1016\/j.mcna.2013.04.005_bib180","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1128\/CMR.15.2.167-193.2002","article-title":"Biofilms: survival mechanisms of clinically relevant microorganisms","volume":"15","author":"Donlan","year":"2002","journal-title":"Clin Microbiol Rev"},{"issue":"5559","key":"10.1016\/j.mcna.2013.04.005_bib181","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1126\/science.295.5559.1487","article-title":"Extracellular DNA required for bacterial biofilm formation","volume":"295","author":"Whitchurch","year":"2002","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.mcna.2013.04.005_bib182","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1097\/00002480-200011000-00037","article-title":"Role of biofilms in antimicrobial resistance","volume":"46","author":"Donlan","year":"2000","journal-title":"ASAIO J"},{"issue":"437","key":"10.1016\/j.mcna.2013.04.005_bib183","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/01.blo.0000175714.68624.74","article-title":"Biofilms and antimicrobial resistance","author":"Patel","year":"2005","journal-title":"Clin Orthop Relat Res"},{"issue":"1","key":"10.1016\/j.mcna.2013.04.005_bib184","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1128\/AAC.00576-06","article-title":"High-level vancomycin-resistant Staphylococcus aureus isolates associated with a polymicrobial biofilm","volume":"51","author":"Weigel","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"10.1016\/j.mcna.2013.04.005_bib185","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1086\/590011","article-title":"Diagnostic accuracy of the physical examination and imaging tests for osteomyelitis underlying diabetic foot ulcers: meta-analysis","volume":"47","author":"Dinh","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.mcna.2013.04.005_bib186","doi-asserted-by":"crossref","first-page":"294","DOI":"10.2337\/diacare.22.2.294","article-title":"Correlation of imaging techniques to histopathology in patients with diabetic foot syndrome and clinical suspicion of chronic osteomyelitis. The role of high-resolution ultrasound","volume":"22","author":"Enderle","year":"1999","journal-title":"Diabetes Care"},{"issue":"7","key":"10.1016\/j.mcna.2013.04.005_bib187","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/S0026-0495(99)90230-5","article-title":"The value of combined radionuclide and magnetic resonance imaging in the diagnosis and conservative management of minimal or localized osteomyelitis of the foot in diabetic patients","volume":"48","author":"Vesco","year":"1999","journal-title":"Metabolism"},{"issue":"4","key":"10.1016\/j.mcna.2013.04.005_bib188","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/S1067-2516(96)80075-5","article-title":"Leukocytosis is a poor indicator of acute osteomyelitis of the foot in diabetes mellitus","volume":"35","author":"Armstrong","year":"1996","journal-title":"J\u00a0Foot Ankle Surg"},{"issue":"9","key":"10.1016\/j.mcna.2013.04.005_bib189","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1001\/jama.1995.03520330051036","article-title":"Probing to bone in infected pedal ulcers. A clinical sign of underlying osteomyelitis in diabetic patients","volume":"273","author":"Grayson","year":"1995","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.mcna.2013.04.005_bib190","doi-asserted-by":"crossref","first-page":"945","DOI":"10.2337\/diacare.29.04.06.dc05-2450","article-title":"Probing the validity of the probe-to-bone test in the diagnosis of osteomyelitis of the foot in diabetes","volume":"29","author":"Shone","year":"2006","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.mcna.2013.04.005_bib191","doi-asserted-by":"crossref","first-page":"270","DOI":"10.2337\/dc06-1572","article-title":"Probe-to-bone test for diagnosing diabetic foot osteomyelitis: reliable or relic?","volume":"30","author":"Lavery","year":"2007","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.mcna.2013.04.005_bib192","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.1464-5491.2010.03150.x","article-title":"Diagnosing diabetic foot osteomyelitis: is the combination of probe-to-bone test and plain radiography sufficient for high-risk inpatients?","volume":"28","author":"Arag\u00f3n-S\u00e1nchez","year":"2011","journal-title":"Diabet Med"},{"issue":"5","key":"10.1016\/j.mcna.2013.04.005_bib193","doi-asserted-by":"crossref","first-page":"369","DOI":"10.7547\/1020369","article-title":"Performance of the probe-to-bone test in a population suspected of having osteomyelitis of the foot in diabetes","volume":"102","author":"Mutluoglu","year":"2012","journal-title":"J\u00a0Am Podiatr Med Assoc"},{"issue":"10","key":"10.1016\/j.mcna.2013.04.005_bib194","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.2337\/dc09-2309","article-title":"Validating the probe-to-bone test and other tests for diagnosing chronic osteomyelitis in the diabetic foot","volume":"33","author":"Morales Lozano","year":"2010","journal-title":"Diabetes Care"},{"issue":"9","key":"10.1016\/j.mcna.2013.04.005_bib195","doi-asserted-by":"crossref","first-page":"445","DOI":"10.7547\/87507315-91-9-445","article-title":"The diagnosis of osteomyelitis in diabetes using erythrocyte sedimentation rate: a pilot study","volume":"91","author":"Kaleta","year":"2001","journal-title":"J\u00a0Am Podiatr Med Assoc"},{"issue":"7","key":"10.1016\/j.mcna.2013.04.005_bib196","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1001\/jama.299.7.806","article-title":"Does this patient with diabetes have osteomyelitis of the lower extremity?","volume":"299","author":"Butalia","year":"2008","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.mcna.2013.04.005_bib197","first-page":"145","article-title":"Comparison of coronary heart disease mortality risk between black and white people with diabetes","volume":"3","author":"DeStefano","year":"1993","journal-title":"Ethn Dis"},{"issue":"1","key":"10.1016\/j.mcna.2013.04.005_bib198","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1177\/107110079301400104","article-title":"Evaluation of magnetic resonance imaging in the diagnosis of osteomyelitis in diabetic foot infections","volume":"14","author":"Weinstein","year":"1993","journal-title":"Foot Ankle"},{"key":"10.1016\/j.mcna.2013.04.005_bib199","series-title":"Essentials of radiology","author":"Mettler","year":"2005"},{"issue":"4","key":"10.1016\/j.mcna.2013.04.005_bib200","doi-asserted-by":"crossref","first-page":"795","DOI":"10.2214\/ajr.152.4.795","article-title":"Osteomyelitis of the foot in diabetic patients: evaluation with plain film, 99mTc-MDP bone scintigraphy, and MR imaging","volume":"152","author":"Yuh","year":"1989","journal-title":"AJR Am J Roentgenol"},{"issue":"6","key":"10.1016\/j.mcna.2013.04.005_bib201","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/0730-725X(90)90017-V","article-title":"MRI and diabetic foot infections","volume":"8","author":"Wang","year":"1990","journal-title":"Magn Reson Imaging"},{"issue":"1","key":"10.1016\/j.mcna.2013.04.005_bib202","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1177\/107110079601700103","article-title":"Prospective study of bone, indium-111-labeled white blood cell, and gallium-67 scanning for the evaluation of osteomyelitis in the diabetic foot","volume":"17","author":"Johnson","year":"1996","journal-title":"Foot Ankle Int"},{"issue":"8","key":"10.1016\/j.mcna.2013.04.005_bib203","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/BF00349857","article-title":"Magnification radiography in osteomyelitis","volume":"15","author":"Lee","year":"1986","journal-title":"Skeletal Radiol"},{"issue":"7","key":"10.1016\/j.mcna.2013.04.005_bib204","first-page":"569","article-title":"Scintigraphic evaluation of diabetic osteomyelitis: concise communication","volume":"23","author":"Park","year":"1982","journal-title":"J\u00a0Nucl Med"},{"issue":"6","key":"10.1016\/j.mcna.2013.04.005_bib205","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/0002-9610(89)90184-0","article-title":"Value of radiographs and bone scans in determining the need for therapy in diabetic patients with foot ulcers","volume":"158","author":"Shults","year":"1989","journal-title":"Am J Surg"},{"issue":"2","key":"10.1016\/j.mcna.2013.04.005_bib206","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/S0741-5214(96)70102-7","article-title":"Role of magnetic resonance imaging in the diagnosis of osteomyelitis in diabetic foot infections","volume":"24","author":"Croll","year":"1996","journal-title":"J\u00a0Vasc Surg"},{"issue":"10","key":"10.1016\/j.mcna.2013.04.005_bib207","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1001\/archinte.1989.00390100078019","article-title":"Diagnosis of pedal osteomyelitis in diabetic patients using current scintigraphic techniques","volume":"149","author":"Keenan","year":"1989","journal-title":"Arch Intern Med"},{"issue":"3","key":"10.1016\/j.mcna.2013.04.005_bib208","doi-asserted-by":"crossref","first-page":"527","DOI":"10.2214\/ajr.157.3.1872240","article-title":"Diagnosis of osteomyelitis of the foot in diabetic patients: value of 111In-leukocyte scintigraphy","volume":"157","author":"Larcos","year":"1991","journal-title":"AJR Am J Roentgenol"},{"issue":"9","key":"10.1016\/j.mcna.2013.04.005_bib209","first-page":"988","article-title":"Effect of soft-tissue pathology on detection of pedal osteomyelitis in diabetics","volume":"26","author":"Seldin","year":"1985","journal-title":"J\u00a0Nucl Med"},{"issue":"3","key":"10.1016\/j.mcna.2013.04.005_bib210","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1177\/107110079401500311","article-title":"Magnetic resonance imaging for the diagnosis of osteomyelitis in the diabetic patient with a foot ulcer","volume":"15","author":"Levine","year":"1994","journal-title":"Foot Ankle Int"},{"issue":"7","key":"10.1016\/j.mcna.2013.04.005_bib211","first-page":"1330","article-title":"Evaluation of infectious diabetic foot complications with indium-111-labeled human nonspecific immunoglobulin G","volume":"33","author":"Oyen","year":"1992","journal-title":"J\u00a0Nucl Med"},{"issue":"6","key":"10.1016\/j.mcna.2013.04.005_bib212","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1086\/514791","article-title":"Use of Sulesomab, a radiolabeled antibody fragment, to detect osteomyelitis in diabetic patients with foot ulcers by leukoscintigraphy","volume":"28","author":"Harwood","year":"1999","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.mcna.2013.04.005_bib213","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/S1067-2516(97)80057-9","article-title":"Diagnosis of pedal osteomyelitis with Tc-99m HMPAO labeled leukocytes","volume":"36","author":"Blume","year":"1997","journal-title":"J\u00a0Foot Ankle Surg"},{"issue":"6","key":"10.1016\/j.mcna.2013.04.005_bib214","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1111\/j.1464-5491.2006.01887.x","article-title":"The diagnosis of osteomyelitis of the foot in diabetes: microbiological examination vs. magnetic resonance imaging and labelled leucocyte scanning","volume":"23","author":"Ertugrul","year":"2006","journal-title":"Diabet Med"},{"issue":"11","key":"10.1016\/j.mcna.2013.04.005_bib215","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.2337\/diacare.15.11.1527","article-title":"Leukocyte scanning with 111In is superior to magnetic resonance imaging in diagnosis of clinically unsuspected osteomyelitis in diabetic foot ulcers","volume":"15","author":"Newman","year":"1992","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1016\/j.mcna.2013.04.005_bib216","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1148\/radiology.203.3.9169715","article-title":"Osteomyelitis of the diabetic foot: MR imaging-pathologic correlation","volume":"203","author":"Craig","year":"1997","journal-title":"Radiology"},{"issue":"1","key":"10.1016\/j.mcna.2013.04.005_bib217","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/BF02042659","article-title":"Prospective evaluation of magnetic resonance imaging in the management of acute diabetic foot infections","volume":"7","author":"Horowitz","year":"1993","journal-title":"Ann Vasc Surg"},{"key":"10.1016\/j.mcna.2013.04.005_bib218","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/pdi.1960160404","article-title":"The detection of pedal osteomyelitis in diabetic patients","volume":"16","author":"Kearney","year":"1999","journal-title":"Practical Diabetes International"},{"issue":"1","key":"10.1016\/j.mcna.2013.04.005_bib219","doi-asserted-by":"crossref","first-page":"215","DOI":"10.2214\/ajr.178.1.1780215","article-title":"Nonenhancing tissue on MR imaging\u00a0of pedal infection: characterization of necrotic tissue and associated limitations for diagnosis of osteomyelitis and abscess","volume":"178","author":"Ledermann","year":"2002","journal-title":"AJR Am J Roentgenol"},{"issue":"2","key":"10.1016\/j.mcna.2013.04.005_bib220","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1097\/00003072-199802000-00003","article-title":"Detection of osteomyelitis in the neuropathic foot: nuclear medicine, MRI and conventional radiography","volume":"23","author":"Lipman","year":"1998","journal-title":"Clin Nucl Med"},{"issue":"2","key":"10.1016\/j.mcna.2013.04.005_bib221","first-page":"97","article-title":"MR imaging of neuropathic feet in leprosy patients with suspected osteomyelitis","volume":"70","author":"Maas","year":"2002","journal-title":"Int J Lepr Other Mycobact Dis"},{"issue":"3","key":"10.1016\/j.mcna.2013.04.005_bib222","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1148\/radiology.207.3.9609883","article-title":"Osteomyelitis of the foot: relative importance of primary and secondary MR imaging signs","volume":"207","author":"Morrison","year":"1998","journal-title":"Radiology"},{"issue":"12","key":"10.1016\/j.mcna.2013.04.005_bib223","doi-asserted-by":"crossref","first-page":"603","DOI":"10.7547\/87507315-82-12-603","article-title":"Clinical impact of magnetic resonance imaging in foot osteomyelitis","volume":"82","author":"Nigro","year":"1992","journal-title":"J\u00a0Am Podiatr Med Assoc"},{"issue":"2","key":"10.1016\/j.mcna.2013.04.005_bib224","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/S0009-9260(98)80058-5","article-title":"99mTc-nanocolloid scintigraphy for assessing osteomyelitis in diabetic neuropathic feet","volume":"53","author":"Remedios","year":"1998","journal-title":"Clin Radiol"},{"issue":"2","key":"10.1016\/j.mcna.2013.04.005_bib225","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1001\/archinte.167.2.125","article-title":"Magnetic resonance imaging for diagnosing foot osteomyelitis: a meta-analysis","volume":"167","author":"Kapoor","year":"2007","journal-title":"Arch Intern Med"},{"issue":"1","key":"10.1016\/j.mcna.2013.04.005_bib226","doi-asserted-by":"crossref","first-page":"119","DOI":"10.2214\/ajr.182.1.1820119","article-title":"MRI findings of septic arthritis and associated osteomyelitis in adults","volume":"182","author":"Karchevsky","year":"2004","journal-title":"AJR Am J Roentgenol"},{"issue":"10","key":"10.1016\/j.mcna.2013.04.005_bib227","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1097\/01.mnm.0000230065.85705.b3","article-title":"Nuclear medicine imaging of diabetic foot infection: results of meta-analysis","volume":"27","author":"Capriotti","year":"2006","journal-title":"Nucl Med Commun"},{"issue":"2","key":"10.1016\/j.mcna.2013.04.005_bib228","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1007\/s002590050205","article-title":"Contribution of technetium-99m hexamethylpropylene amine oxime labelled leucocyte scintigraphy to the diagnosis of diabetic foot infection","volume":"25","author":"Devillers","year":"1998","journal-title":"Eur J Nucl Med"},{"issue":"3","key":"10.1016\/j.mcna.2013.04.005_bib229","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S1067-2516(97)80117-2","article-title":"Technetium-99-labeled leukocytes in diagnosing diabetic osteomyelitis in the foot","volume":"36","author":"Harvey","year":"1997","journal-title":"J\u00a0Foot Ankle Surg"},{"issue":"12","key":"10.1016\/j.mcna.2013.04.005_bib230","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1097\/00003072-200112000-00005","article-title":"Comparison of Tc-99m methylene diphosphonate, Tc-99m human immune globulin, and Tc-99m-labeled white blood cell scintigraphy in the diabetic foot","volume":"26","author":"Unal","year":"2001","journal-title":"Clin Nucl Med"},{"issue":"4","key":"10.1016\/j.mcna.2013.04.005_bib231","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/00003072-200004000-00009","article-title":"Exclusion of chronic osteomyelitis with F-18 fluorodeoxyglucose positron emission tomographic imaging","volume":"25","author":"Zhuang","year":"2000","journal-title":"Clin Nucl Med"},{"issue":"5","key":"10.1016\/j.mcna.2013.04.005_bib232","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1007\/s002590050538","article-title":"Fluorine-18 fluorodeoxyglucose PET in infectious bone diseases: results of histologically confirmed cases","volume":"27","author":"Kalicke","year":"2000","journal-title":"Eur J Nucl Med"},{"issue":"1","key":"10.1016\/j.mcna.2013.04.005_bib233","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s00259-001-0661-9","article-title":"Chronic bacterial osteomyelitis: prospective comparison of (18)F-FDG imaging with a dual-head coincidence camera and\u00a0(111)In-labelled autologous leucocyte scintigraphy","volume":"29","author":"Meller","year":"2002","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"3","key":"10.1016\/j.mcna.2013.04.005_bib234","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1148\/radiology.206.3.9494496","article-title":"Chronic osteomyelitis: detection with FDG PET and correlation with histopathologic findings","volume":"206","author":"Guhlmann","year":"1998","journal-title":"Radiology"},{"issue":"12","key":"10.1016\/j.mcna.2013.04.005_bib235","first-page":"2145","article-title":"Fluorine-18-FDG PET and technetium-99m antigranulocyte antibody scintigraphy in chronic osteomyelitis","volume":"39","author":"Guhlmann","year":"1998","journal-title":"J\u00a0Nucl Med"},{"issue":"5","key":"10.1016\/j.mcna.2013.04.005_bib236","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1007\/s00259-006-0290-4","article-title":"Diagnostic value of 18F-FDG PET\/CT in trauma patients with suspected chronic osteomyelitis","volume":"34","author":"Hartmann","year":"2007","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"6","key":"10.1016\/j.mcna.2013.04.005_bib237","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1097\/MNM.0b013e328174447f","article-title":"Potential role of FDG PET in the setting of diabetic neuro-osteoarthropathy: can it differentiate uncomplicated Charcot's neuroarthropathy from osteomyelitis and soft-tissue infection?","volume":"28","author":"Basu","year":"2007","journal-title":"Nucl Med Commun"},{"issue":"3","key":"10.1016\/j.mcna.2013.04.005_bib238","first-page":"444","article-title":"The diabetic foot: initial experience with 18F-FDG PET\/CT","volume":"46","author":"Keidar","year":"2005","journal-title":"J\u00a0Nucl Med"},{"issue":"1","key":"10.1016\/j.mcna.2013.04.005_bib239","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1365-2796.2007.01877.x","article-title":"Unsuspected osteomyelitis is frequent in persistent diabetic foot ulcer and better diagnosed by MRI than by 18F-FDG PET or 99mTc-MOAB","volume":"263","author":"Schwegler","year":"2008","journal-title":"J\u00a0Intern Med"},{"issue":"10","key":"10.1016\/j.mcna.2013.04.005_bib240","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1007\/s00259-012-2183-z","article-title":"FDG PET\/CT imaging in the diagnosis of osteomyelitis in the diabetic foot","volume":"39","author":"Kagna","year":"2012","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"3","key":"10.1016\/j.mcna.2013.04.005_bib241","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s11307-009-0268-2","article-title":"Diagnostic performance of FDG-PET, MRI, and plain film radiography (PFR) for the diagnosis of osteomyelitis in the diabetic foot","volume":"12","author":"Nawaz","year":"2010","journal-title":"Mol Imaging Biol"},{"issue":"7","key":"10.1016\/j.mcna.2013.04.005_bib242","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1086\/597263","article-title":"Needle puncture and transcutaneous bone biopsy cultures are inconsistent in patients with diabetes and suspected osteomyelitis of the foot","volume":"48","author":"Senneville","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"7","key":"10.1016\/j.mcna.2013.04.005_bib243","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1111\/j.1464-5491.2004.01221.x","article-title":"Swab cultures accurately identify bacterial pathogens in diabetic foot wounds not involving bone","volume":"21","author":"Slater","year":"2004","journal-title":"Diabet Med"},{"issue":"1","key":"10.1016\/j.mcna.2013.04.005_bib244","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1464-5491.2005.01764.x","article-title":"Comparison of microbiological results of needle puncture vs. superficial swab in infected diabetic foot ulcer with osteomyelitis","volume":"23","author":"Kessler","year":"2006","journal-title":"Diabet Med"},{"issue":"Suppl 2","key":"10.1016\/j.mcna.2013.04.005_bib245","doi-asserted-by":"crossref","first-page":"S115","DOI":"10.1086\/383272","article-title":"Controversies in diagnosing and managing osteomyelitis of the foot in diabetes","volume":"39","author":"Jeffcoate","year":"2004","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.mcna.2013.04.005_bib246","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1093\/clinids\/23.2.286","article-title":"Can aggressive treatment of diabetic foot infections reduce the need for above-ankle amputation?","volume":"23","author":"Tan","year":"1996","journal-title":"Clin Infect Dis"},{"issue":"11","key":"10.1016\/j.mcna.2013.04.005_bib247","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.2337\/diacare.19.11.1257","article-title":"Treatment of osteomyelitis in the diabetic foot. Contribution of conservative surgery","volume":"19","author":"Ha Van","year":"1996","journal-title":"Diabetes Care"},{"issue":"8","key":"10.1016\/j.mcna.2013.04.005_bib248","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1001\/archinte.159.8.851","article-title":"Outcome of diabetic foot infections treated conservatively: a retrospective cohort study with long-term follow-up","volume":"159","author":"Pittet","year":"1999","journal-title":"Arch Intern Med"},{"issue":"3","key":"10.1016\/j.mcna.2013.04.005_bib249","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1302\/0301-620X.83B3.10727","article-title":"Chronic osteomyelitis. The effect of the extent of surgical resection on infection-free survival","volume":"83","author":"Simpson","year":"2001","journal-title":"J\u00a0Bone Joint Surg Br"},{"issue":"6","key":"10.1016\/j.mcna.2013.04.005_bib250","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1097\/01.sla.0000164172.28918.3f","article-title":"Osteomyelitis of the foot and toe in adults is a surgical disease: conservative management worsens lower extremity salvage","volume":"241","author":"Henke","year":"2005","journal-title":"Ann Surg"},{"issue":"6","key":"10.1016\/j.mcna.2013.04.005_bib251","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1002\/(SICI)1096-9136(199706)14:6<487::AID-DIA373>3.0.CO;2-Q","article-title":"Conservative management of osteomyelitis in the feet of diabetic patients","volume":"14","author":"Venkatesan","year":"1997","journal-title":"Diabet Med"},{"issue":"6","key":"10.1016\/j.mcna.2013.04.005_bib252","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1093\/jac\/48.6.927","article-title":"Rifampicin-ofloxacin oral regimen for the treatment of mild to moderate diabetic foot osteomyelitis","volume":"48","author":"Senneville","year":"2001","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"5","key":"10.1016\/j.mcna.2013.04.005_bib253","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1111\/j.1365-2133.2004.06170.x","article-title":"Rapid healing of intractable diabetic foot ulcers with exposed bones following a novel therapy of exposing bone marrow cells and then grafting epidermal sheets","volume":"151","author":"Yamaguchi","year":"2004","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1016\/j.mcna.2013.04.005_bib254","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1177\/107110079801900309","article-title":"Treatment of diabetic (neuropathic) foot ulcers with two-stage debridement and closure","volume":"19","author":"Kumagi","year":"1998","journal-title":"Foot Ankle Int"},{"issue":"4","key":"10.1016\/j.mcna.2013.04.005_bib255","first-page":"306","article-title":"Osteomyelitis associated with vascular insufficiency","volume":"16","author":"Kerstein","year":"1974","journal-title":"Curr Ther Res Clin Exp"},{"issue":"1","key":"10.1016\/j.mcna.2013.04.005_bib256","first-page":"29","article-title":"Panmetatarsal head resection and transmetatarsal amputation versus solitary partial ray resection in the neuropathic foot","volume":"30","author":"Cohen","year":"1991","journal-title":"J\u00a0Foot Surg"},{"issue":"4","key":"10.1016\/j.mcna.2013.04.005_bib257","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1053\/j.jfas.2006.04.002","article-title":"The role of early surgical debridement and revascularization in patients with diabetes and deep foot space abscess: retrospective review of 106 patients with diabetes","volume":"45","author":"Faglia","year":"2006","journal-title":"J\u00a0Foot Ankle Surg"},{"issue":"3","key":"10.1016\/j.mcna.2013.04.005_bib258","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/S1067-2516(97)80116-0","article-title":"The natural history of great toe amputations","volume":"36","author":"Murdoch","year":"1997","journal-title":"J\u00a0Foot Ankle Surg"},{"issue":"2","key":"10.1016\/j.mcna.2013.04.005_bib259","doi-asserted-by":"crossref","first-page":"165","DOI":"10.2337\/diacare.19.2.165","article-title":"The development of foot deformities and ulcers after great toe amputation in diabetes","volume":"19","author":"Quebedeaux","year":"1996","journal-title":"Diabetes Care"},{"issue":"11","key":"10.1016\/j.mcna.2013.04.005_bib260","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.2337\/diacare.18.11.1460","article-title":"Increased foot pressures after great toe amputation in diabetes","volume":"18","author":"Lavery","year":"1995","journal-title":"Diabetes Care"},{"issue":"8","key":"10.1016\/j.mcna.2013.04.005_bib261","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.2337\/diacare.24.8.1442","article-title":"Effectiveness of the diabetic foot risk classification system of the International Working Group on the Diabetic Foot","volume":"24","author":"Peters","year":"2001","journal-title":"Diabetes Care"},{"issue":"6","key":"10.1016\/j.mcna.2013.04.005_bib262","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/S1067-2516(97)80095-6","article-title":"Outcomes of transmetatarsal amputations in patients with diabetes mellitus","volume":"36","author":"Hosch","year":"1997","journal-title":"J\u00a0Foot Ankle Surg"},{"issue":"3","key":"10.1016\/j.mcna.2013.04.005_bib263","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ijid.2004.09.009","article-title":"Antibiotic treatment of osteomyelitis: what have\u00a0we learned from 30 years of clinical trials?","volume":"9","author":"Lazzarini","year":"2005","journal-title":"Int J Infect Dis"},{"issue":"8","key":"10.1016\/j.mcna.2013.04.005_bib264","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1111\/j.1469-0691.2009.03067.x","article-title":"Piperacillin\/tazobactam versus imipenem\/cilastatin for severe diabetic foot infections: a prospective, randomized clinical trial in a university hospital","volume":"16","author":"Saltoglu","year":"2010","journal-title":"Clin Microbiol Infect"},{"issue":"4","key":"10.1016\/j.mcna.2013.04.005_bib265","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1177\/153857449703100403","article-title":"Prospective, randomized comparison of ampicillin\/sulbactam\u00a0and cefoxitin for diabetic foot infections","volume":"31","author":"Erstad","year":"1997","journal-title":"Vasc Surg"},{"issue":"3","key":"10.1016\/j.mcna.2013.04.005_bib266","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1093\/cid\/cir842","article-title":"Systemic antibiotic therapy for chronic osteomyelitis in adults","volume":"54","author":"Spellberg","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.mcna.2013.04.005_bib267","doi-asserted-by":"crossref","first-page":"518","DOI":"10.3109\/17453679808997790","article-title":"Osteomyelitis treated with gentamicin-PMMA beads: 100 patients followed for 1-12 years","volume":"69","author":"Walenkamp","year":"1998","journal-title":"Acta Orthop Scand"},{"issue":"14","key":"10.1016\/j.mcna.2013.04.005_bib268","first-page":"934","article-title":"Gentamicin-PMMA-beads in treating bone and soft tissue infections","volume":"104","author":"Klemm","year":"1979","journal-title":"Zentralbl Chir"},{"issue":"295","key":"10.1016\/j.mcna.2013.04.005_bib269","first-page":"8","article-title":"Comparison of the clinical efficacy and tolerance of gentamicin PMMA beads on surgical wire versus combined and systemic therapy for osteomyelitis","author":"Blaha","year":"1993","journal-title":"Clin Orthop Relat Res"},{"issue":"6","key":"10.1016\/j.mcna.2013.04.005_bib270","first-page":"338","article-title":"Results of long-term therapy of chronic, post-traumatic osteomyelitis with gentamycin PMMA chains","volume":"98","author":"Jerosch","year":"1995","journal-title":"Unfallchirurg"},{"issue":"5","key":"10.1016\/j.mcna.2013.04.005_bib271","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.ijantimicag.2011.03.008","article-title":"To bead or not to bead? Treatment of osteomyelitis and prosthetic joint associated infections with gentamicin bead chains","volume":"38","author":"Barth","year":"2011","journal-title":"Int J Antimicrob Agents"},{"issue":"18","key":"10.1016\/j.mcna.2013.04.005_bib272","doi-asserted-by":"crossref","first-page":"3033","DOI":"10.1517\/14656560903397398","article-title":"Pharmacotherapy of diabetic foot osteomyelitis","volume":"10","author":"Byren","year":"2009","journal-title":"Expert Opin Pharmacother"},{"issue":"1","key":"10.1016\/j.mcna.2013.04.005_bib273","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1093\/clinids\/10.1.103","article-title":"Lessons learned from animal models of osteomyelitis","volume":"10","author":"Norden","year":"1988","journal-title":"Rev Infect Dis"},{"issue":"Suppl","key":"10.1016\/j.mcna.2013.04.005_bib274","first-page":"1","article-title":"Consensus statement on negative pressure wound therapy (V.A.C. Therapy) for the management of diabetic foot wounds","author":"Andros","year":"2006","journal-title":"Ostomy Wound Manage"}],"container-title":["Medical Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025712513000618?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025712513000618?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,11]],"date-time":"2024-05-11T21:07:52Z","timestamp":1715461672000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025712513000618"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":274,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["S0025712513000618"],"URL":"https:\/\/doi.org\/10.1016\/j.mcna.2013.04.005","relation":{},"ISSN":["0025-7125"],"issn-type":[{"value":"0025-7125","type":"print"}],"subject":[],"published":{"date-parts":[[2013,9]]}}}